Date |
Speaker |
Presentation Title |
17/09/14 |
Helen Tyrell & John Hornell |
Auckland Statement - Report Card |
17/09/14 |
John Ward |
From Data to Policy: Hepatitis B and Hepatitis C Prevention Policies in the United States |
17/09/14 |
Alex Thompson |
State of the Art – Interferon-free therapy for hepatitis C |
17/09/14 |
Alison Coelho |
Addressing Hepatitis B through Community Action |
|
|
|
17/09/14 |
Michelle Micallef |
Treatment for Hepatitis C virus infection among people who inject drugs in the opioid substitution setting: The ETHOS Study |
17/09/14 |
Carla Treloar |
Evaluation of Two Community-Controlled Peer Support Programs for Assessment and Treatment of Hepatitis C Virus Infection in Opioid Substitution Treatment Clinics: The Ethos Study, Australia |
17/09/14 |
Michelle Micallef |
Liverlife: A Healthy Liver Campaign among People Who Inject Drugs in the Drug and Alcohol Setting |
17/09/14 |
Nicky Bath |
Liver Mates: Why must the affected community be supported to lead on the development and delivery of hepatitis C treatment and healthy liver interventions? |
|
|
|
17/9/14 |
Benjamin Cowie |
Epidemiology of chronic hepatitis B in key priority populations - similarities and differences |
|
|
|
18/9/14 |
Giten Khwairakpam |
Advocating for access to HCV treatment: Community experiences from Asia |
|
|
|
18/09/14 |
Jason Grebely |
Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012 |
18/09/14 |
Bethany White |
Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study |
18/09/14 |
Jennifer MacLachlan |
Trends in chronic hepatitis B diagnosis In Australia, 2009-2013 |
18/09/14 |
Maryam Alavi |
Time to Hepatocellular Carcinoma after Notification of Hepatitis B or C Infection: A Population-Based Cohort Study, 1992–2007 |
|
|
|
18/09/14 |
Carolyn Day |
The role of financial incentives in developing hepatitis B immunity following accelerated vaccination among people who inject drugs in Sydney, Australia: randomised controlled trial |
18/09/14 |
Gillian Rosenberg |
Treating Immune-tolerant HBV: Factors Associated with Significant Decline in HBeAg and HBsAg Levels |
18/09/14 |
Tracey Cabrie |
Improving quality of care for people living with hepatitis B in primary care: preliminary data from the Integrated Hepatitis B Service |
18/09/14 |
Sarah Beynon |
Management of Hepatitis B during pregnancy at Geelong Hospital: a retrospective review |
|
|
|
18/09/14 |
Suzanne Fraser |
Everyday objects and injecting: Why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment? |
18/09/14 |
Jake Rance |
Negotiating risk, navigating relationship: accounts of needle-syringe sharing within romantic partnerships
|
18/09/14 |
Carla Treloar |
Innovation in Hepatitis C Prevention: A Trial of Symbiotic and Pleasure-Based Messages with NSP Staff and Clients |
18/09/14 |
Yvonne Samuel |
Peer Education the forgotten tool for fighting viral hepatitis |
18/09/14 |
Sione Crawford |
Building on Shaky Ground - a Peer Educator and Peer Leader Program in the ACT
|
18/09/14 |
Carla Treloar |
Acquiring Hepatitis C in Prison: A Qualitative Study of the HITSP Cohort |
|
|
|
18/09/14 |
Angella Duvnjak |
So Heppy Together: Perceptions of peers and its impact on south-south hepatitis C capacity building collaborations |
18/09/14 |
Lana Pocock |
Hepatitis workforce development: A decade of learning The ABCs |
18/09/14 |
Bradley Whitton |
Improving chlamydia and hepatitis C awareness through a sexual and reproductive health education program for Aboriginal and Torres Strait Islander students in Victorian secondary schools |
|
|
|
18/09/14 |
Maggie Bassendine |
HBV Reactivation: Playing with fire |
|
|
|
18/09/14 |
Annie Madden |
Introduction and overview: why are human rights, the law and discrimination important in viral hepatitis |
18/09/14 |
Bridget Akers |
Vignette 3 – Workplace discrimination |
|
|
|
18/09/14 |
Nadia Warner |
How does hepatitis cause liver cancer? |
18/09/14 |
Scott Bowden |
Novel diagnostics in viral hepatitis – how can they address the liver cancer burden? |
18/09/14 |
Josh Davis |
Liver cancer in the Northern Territory – recent data and how it can guide diagnosis and management |
18/09/14 |
Monica Robotin |
The National Liver Cancer Prevention Policy and future policy directions for Australian Cancer Councils |
18/09/14 |
Monica Robotin |
Launch - Liver cancer resource for people affected by primary liver cancer in four languages
|
|
|
|
18/09/14 |
Nicole Allard |
The cascade of care for people living with chronic hepatitis B: access to treatment and monitoring in Australia |
18/09/14 |
Jason Grebely |
The HCV Care Cascade: Mapping the HCV clinical care pathway in Australia |
18/09/14 |
Enaam Oudih |
Cultural lenses – Pathways to care from prevention to treatment |
|
|
|
18/09/14 |
Rebecca Katiforis |
Successes and challenges of delivering hepatits C nursing care in the Top End
|
18/09/14 |
Frances Tenison & Damian House |
From Treatment to Peer Worker |
18/09/14 |
Jacqui Richmond |
Hepatology Nursing in the Era of Expanding Hepatitis C Evidence |
18/09/14 |
Rosalie Altus |
Hepatitis C in SA from Tertiary to Primary Care |
|
|
|
18/09/14 |
Judith Bevan |
Chronic Hepatitis Primary Care Pathway |
18/09/14 |
Nicky Bath |
Livermates
|
|
|
|
18/09/14 |
Alex Thompson |
Genetic determinants of HCV treatment outcome
|
18/09/14 |
Jun Gu |
Hepatitis C virus can accumulate mutations that confer resistance to a novel broadly neutralizing antibody MAb24
|
18/09/14 |
Silvana Gaudieri |
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C |
18/09/14 |
Eric Gowans |
Cytolytic DNA vaccines enhance immunity to hepatitis C virus |
|
|
|
19/096/14 |
Maggie Bassendine |
Hepatitis C genotype 3 infection – Is it the new Genotype 1? |
19/09/14 |
Greg Dore |
Expanding access to hepatitis C treatment through primary care: challenges and opportunities |
|
|
|
19/09/14 |
Jenny Iversen |
NSP in urban, rural and regional settings – distribution models and viral hepatitis prevention coverage |
19/09/14 |
Adrian Dunlop |
Providing OST in rural/regional settings – what are the opportunities to enhance viral hepatitis prevention and care |
19/09/14 |
Phillip Read |
Integrated viral hepatitis primary care models in rural and regional settings – Insights from the Kirketon Road Centre |
19/09/14 |
Nicky Bath |
BBV prevention in Aboriginal communities: the perspectives of Aboriginal PWID from the RISE Project |
|
|
|
19/09/14 |
Jack Wallace |
No vaccination against discrimination: Chinese Viral Hepatitis Needs Assessment |
19/09/14 |
Marina Suarez |
Tradition and Innovation Working Hand in Hand: Engaging Communities Affected by Chronic Hepatitis B |
19/09/14 |
Sharna Ciotti |
Know Your Hepatitis B Status (with African communities) |
|
|
|
19/09/14 |
Marc Pellegrini |
Novel therapeutic that kills HBV infected cells
|
19/09/14 |
Margaret Littlejohn |
Prevalence and Molecular Virology of Hepatitis Delta Virus in the Western Pacific Region
|
|
|
|
19/09/14 |
Dhruba Acharya |
Trends of hepatitis B surface antigen carriage in central Nepal: a reality check from a mass screening after nationwide HBV vaccination |
19/09/14 |
Jennifer MacLachlan |
Estimating uptake of treatment for chronic hepatitis B infection across Australia |
19/09/14 |
Monica Robotin |
Characteristics of chronic hepatitis B infection in SW Sydney: clinical correlates and policy implications |
19/09/14 |
Kevin Marriott |
Champions and challenges in Australia’s response to Blood Borne Viruses |
|
|
|
19/09/14 |
Behzad Hajarizadeh |
Factors Associated with Hepatitis C Virus Rna Levels in Early Acute and Early Chronic Infection: The Inc3 Study
|
19/09/14 |
Maryam Alavi |
Effect of Treatment Willingness on Specialist Assessment and Treatment Uptake for Hepatitis C Virus Infection among People Who Use Drugs: The Ethos Study |
19/09/14 |
Greg Dore |
Regression of advanced fibrosis following virological response to anti-HCV therapy |
19/09/14 |
Stuart Roberts |
Efficacy and Safety of Daclatasvir in Combination with Asunaprevir (Dcv+Asv) in Cirrhotic and Non-Cirrhotic Patients with Hcv Genotype 1b: Results of the Hallmark Dual Study |
19/09/14 |
Anna Olsen |
Treating hepatitis C: Does gender matter? |
|
|
|
19/09/14 |
Jacqui Richmond |
Psychosocial Health among People with Chronic Hepatitis B in Australia |
19/09/14 |
Jacqui Richmond |
Hepatitis C and Ageing: Perspectives from the Clinical, Community and Government Sectors |
19/09/14 |
Andrew Bamblett & Peter Waples-Crowe |
Yarning about Hep C; Aboriginal Victorians telling our stories about living with Hep C |
19/096/14 |
Kerry Walker |
Your Mob, My Mob, Our Mob (YMMMOM) Peer Education Project |
|
|
|
19/09/14 |
Rosalind Edwards |
Hepatitis B Virus in African immigrants living in Australia |
19/09/14 |
Scott Bowden |
Use of Biomarkers to Monitor HBV Therapy |
|
|
|
19/09/14 |
Behzad Hajarizadeh |
Hepatitis B Knowledge among People with Chronic Hepatitis B in Australia |
19/09/14 |
Peter Waples-Crowe |
Increasing the Victorian ACCHO response to injecting drugs and hepatitis c prevention |
19/09/14 |
Zoe Stephens |
The impact of overseas hepatitis B vaccination programs on the future burden of hepatitis B in Australia |
19/09/14 |
Luke McCredie |
Incident hepatitis B infection and immunisation uptake in Australian prison inmates |
|
|
|
19/09/14 |
John Hornell |
Pilot for a community-based assessment and support programme for hepatitis C in New Zealand |
19/09/14 |
James Elliott |
No prejudice! Being a prisoner, indigenous or having a psychiatric illness should not limit access to treatment for chronic hepatitis c infection |
19/09/14 |
David Baker |
Treating Hepatitis C in Primary Care: Results from a Pilot Program |
|
|
|
19/09/14 |
Victoria Sublette |
Psychosocial Factors Influencing Successful Interferon-Based Hepatitis C Treatment Outcomes |
19/09/14 |
Erin Devine |
Fibroscan Testing as a Community Engagement Strategy |
19/09/14 |
Gabrielle Bennett |
Evaluation of “The hepatitis B story” – an educational resource to use in discussion with people who have low health literacy |
19/09/14 |
Jodie Walton |
Looking Beyond the Bars – The first hepatitis C treatment program in Qld for women in custody |
|
|
|
19/09/14 |
Evan Cunningham |
Phylogenetic clustering of Hepatitis C among street-involved youth in Vancouver, Canada |
19/09/14 |
Brendan Jacka |
Molecular epidemiology of hepatitis C virus infections among people who inject drugs in Vancouver, Canada |
19/09/14 |
Tanya Applegate |
Factors associated with phylogenetic clustering of acute hepatitis C virus infection in Australia |
19/09/14 |
Behzad Hajarizadeh |
Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study |
|
|
|
19/09/14 |
Greg Dore |
Debate - Hepatitis C vaccine development is still required in the era of vastly improved treatment |
19/09/14 |
Melanie Eagle |
Debate - Despite the availability of effective treatments and vaccination for hepatitis B, we should prioritise funding for research to find a cure |